Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 11 results found. Search for [ Joe-C-Mathew-|-PB-Jayakumar ]

Results 1 to 11 of 11
PB Jayakumar | Joe C Mathew
April 28, 2021
Low import duty of 10% made local manufacturing unviable for domestic manufacturers, resulting in a free flow of imports of concentrators, particularly from China. As an emergency measure, Centre removed this duty also 2 days ago to allow un-interrupted imports until the situation improves


PB Jayakumar and Joe C Mathew
New Delhi, March 31, 2021
Private equity and overseas companies are taking over domestic healthcare chains, creating a new pecking order


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
A blow-by-blow account of how Indian vaccines are being readied


PB Jayakumar & Joe C Mathew
October 26, 2020
Zydus Cadila's COVID-19 candidate vaccine ZyCov-D, which is currently undergoing second phase of clinical trials in India, is likely to enter Phase III final stage of clinical trials by December 2020


PB Jayakumar | Joe C Mathew
October 25, 2020
Coronavirus vaccine administered through the intramuscular injection route protects the lower lungs but not the upper lung. Nasal vaccines can protect the lungs completely and stop transmission and also infection


PB Jayakumar & Joe C Mathew
October 22, 2020
Serum has floated a new company Serum Institute Life Sciences (SILS) that will exclusively focus on developing, producing and supplying pandemic vaccines


PB Jayakumar & Joe C Mathew
October 22, 2020
There is not a single instance in history of a vaccine that has been discontinued


Joe C Mathew | PB Jayakumar
March 4, 2020
'Right now, the focus is  about 80% innovative medicines and 20 per cent generics. We have 15 launches coming up in innovative medicines,' Novartis International CEO said


Joe C Mathew and PB Jayakumar
March 3, 2020
Novartis has completed strategic transactions worth over $70 billion since he took charge as CEO in 2018. In an exclusive interview with Business Today's Joe C. Mathew and P.B. Jayakumar, the second generation Indian American speaks about his vision for Novartis, new launches in India and the growing role of its Hyderabad centre


Joe C Mathew and PB Jayakumar
New Delhi, February 17, 2020
In an interview with Business Today, Narasimhan said expanding our knowledge base about such disease outbreak is important in order to take effective actions to address them


PAGES 1 OF 1